Dr. Firas H. Al-Kawas, MD

Dr. Al-Kawas practices at Inova Fairfax Hospital - Unit in Falls Church, Virginia.

Dr. Al-Kawas' NPI, 1295733384, was assigned on July 12, 2005. Dr. Al-Kawas holds Virginia license 0101269318.

Dr. Al-Kawas' primary practice is Inova Fairfax Hospital - Unit, at 3300 Gallows Rd, Falls Church, VA 22046 in Falls Church City. The practice phone is (703) 698-3659.

Dr. Al-Kawas' primary practice is Inova Fairfax Hospital - Unit in Falls Church, Virginia. Dr. Al-Kawas is also affiliated with Inova Fairfax Hospital. The medical group on file is Inova Urgent Care Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Kawas practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Al-Kawas' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Al-Kawas' licenses on file in 3 states: Virginia, District of Columbia and Maryland.

CMS data shows 27 Medicare services from Dr. Al-Kawas across 2 procedure codes in 2024, for 54 Medicare patients. Medicare paid $1,922 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 54 Medicare patients who saw Dr. Al-Kawas in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Al-Kawas' median patient age at 69, with 51% women.

In 2024, Dr. Al-Kawas wrote 37 Medicare Part D claims for 22 patients. 86% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $690 in total drug cost. In 2022, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Al-Kawas for performance year 2024, reported as part of a group. Dr. Al-Kawas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Al-Kawas as offering telehealth. CMS counts 42 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Al-Kawas, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Al-Kawas, published from 2011 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Colonic Polyps, Colonoscopy and Bile Duct Neoplasms. Dr. Al-Kawas has published most often in Gastrointest Endosc. Dr. Al-Kawas' most frequent co-authors are Mouen A. Khashab, MD, Heiko Pohl, MD and Fadi Antaki, MD.

CMS Open Payments shows 46 general payments to Dr. Al-Kawas from 8 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 79% of the total. GlaxoSmithKline, LLC. paid the most, $17,700. It also lists 1 research payment totaling $524 in 2018.